Psychedelic Stocks

ContentsField Trip Receives A Price Target With A Buy Rating, Launches New Therapist ProgramsThe DEA Seeks To Increase Federal Production...

MIAMI, October 19, 2021--(BUSINESS WIRE)--Emotional Intelligence Ventures, led by noted investor and exec David Nikzad, are pleased to announce their...

The Miami-based telemedicine startup NUE Life Health is aiming to become an early leader in combining digital mental health therapy...

Compass Pathways stock plunged Tuesday, even as the London-based psychedelic-drug developer said a strong dose of its psilocybin-based drug helped...

MONTREAL, Jan. 24, 2022 /CNW/ - The Good Shroom Co. Inc. (the "Company" or "TGSC") (TSXV: MUSH) is pleased to...

This story is part of a new Prospect series called Rollups, looking at obscure markets that have been rolled up...

Another Psychedelics article, and once again I try to answer the question: is it time to buy the dips in...

Last week, I reported for Psychedelic Spotlight that famed investor Cathie Woods was dipping her toes into the world of...

Psilocybin, a psychedelic, showed promise for treating depression, a study indicated. Psilocybin, combined with therapy, had "enduring" effects in controlled...

A separate, smaller experiment that was included in the Nature Medicine paper appeared to support the notion that psilocybin therapy...